ISH0688
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISH0688, covering 2026-04-01 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: First-in-Human Study of ISH0688: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics [Phase 1]